166 related articles for article (PubMed ID: 34246994)
21. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of endoscopic and microscopic adenoma removal in acromegaly.
Vassilyeva N; Mena N; Kirov K; Diatlova E
Front Endocrinol (Lausanne); 2023; 14():1128345. PubMed ID: 37766690
[TBL] [Abstract][Full Text] [Related]
23. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
[TBL] [Abstract][Full Text] [Related]
24. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D; Hlavica M; Schmid C; Bernays RL
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[TBL] [Abstract][Full Text] [Related]
26. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country.
Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M
Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607
[TBL] [Abstract][Full Text] [Related]
27. Final Outcome in Growth Hormone-Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment.
Torres A; Sanmillan JL; Lau R; Gabarros A
World Neurosurg; 2021 Oct; 154():e292-e301. PubMed ID: 34252630
[TBL] [Abstract][Full Text] [Related]
28. Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications.
Chen CJ; Ironside N; Pomeraniec IJ; Chivukula S; Buell TJ; Ding D; Taylor DG; Dallapiazza RF; Lee CC; Bergsneider M
Acta Neurochir (Wien); 2017 Nov; 159(11):2193-2207. PubMed ID: 28913667
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis.
Li A; Liu W; Cao P; Zheng Y; Bu Z; Zhou T
World Neurosurg; 2017 May; 101():236-246. PubMed ID: 28104521
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative Magnetic Resonance Imaging During Endoscopic Transsphenoidal Surgery of Growth Hormone-Secreting Pituitary Adenomas.
Netuka D; Májovský M; Masopust V; Belšán T; Marek J; Kršek M; Hána V; Ježková J; Hána V; Beneš V
World Neurosurg; 2016 Jul; 91():490-6. PubMed ID: 27150652
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
Ceylan S; Koc K; Anik I
J Neurosurg; 2010 Jan; 112(1):99-107. PubMed ID: 19480546
[TBL] [Abstract][Full Text] [Related]
33. Management of growth hormone-secreting pituitary adenomas causing acromegaly: a practical review of surgical and multimodal management strategies for neurosurgeons.
Cheok SK; Carmichael JD; Zada G
J Neurosurg; 2024 May; 140(5):1285-1294. PubMed ID: 37948697
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.
Dallapiazza R; Bond AE; Grober Y; Louis RG; Payne SC; Oldfield EH; Jane JA
J Neurosurg; 2014 Sep; 121(3):511-7. PubMed ID: 24995783
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
36. Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy.
Wang Z; Guo X; Gao L; Feng C; Lian W; Deng K; Bao X; Feng M; Wang R; Xing B
World Neurosurg; 2019 Feb; 122():e1137-e1145. PubMed ID: 30447463
[TBL] [Abstract][Full Text] [Related]
37. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC; Postma MR; Wolters TLC; van Meyel SWF; Netea-Maier R; van Beek AP; Neggers SJCMM
J Clin Endocrinol Metab; 2021 May; 106(6):1783-1792. PubMed ID: 33544833
[TBL] [Abstract][Full Text] [Related]
38. Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomant.
Lüdecke DK; Crock PA; Bidlingmaier M; Schuppert F
Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):509-12. PubMed ID: 23765756
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic versus microscopic approach for surgical treatment of acromegaly.
Fathalla H; Cusimano MD; Di Ieva A; Lee J; Alsharif O; Goguen J; Zhang S; Smyth H
Neurosurg Rev; 2015 Jul; 38(3):541-8; discussion 548-9. PubMed ID: 25666392
[TBL] [Abstract][Full Text] [Related]
40. Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.
Shepard MJ; Elzoghby MA; Ghanim D; Lopes MBS; Jane JA
World Neurosurg; 2017 Dec; 108():310-316. PubMed ID: 28887280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
